ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.26X leverage
Performance
- Low
- ₹8,971
- High
- ₹9,220
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,971
- Previous Close₹8,961
- Volume24,185
- 50 DMA₹8,709.90
- 100 DMA₹8,799.62
- 200 DMA₹8,644.10
Investment Returns
- Over 1 Month + 8.73%
- Over 3 Month -0.17%
- Over 6 Month + 3.23%
- Over 1 Year + 20.15%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 112.8
- PEG Ratio
- 1.1
- Market Cap Cr
- 22,670
- P/B Ratio
- 28.4
- Average True Range
- 196.57
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -19.42
- RSI
- 70.01
- MFI
- 65.7
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹9,068.00
+
107.5
(1.2%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹8,639.39
- 50 Day
- ₹8,709.90
- 100 Day
- ₹8,799.62
- 200 Day
- ₹8,644.10
Resistance and Support
9086.17
- R3 9,451.33
- R2 9,335.67
- R1 9,201.83
- S1 8,952.33
- S2 8,836.67
- S3 8,702.83
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹9,068 As on 11 February, 2026 | 22:13
The Market Cap of AstraZeneca Pharma India is ₹22670 Cr As on 11 February, 2026 | 22:13
The P/E ratio of AstraZeneca Pharma India is 112.8 As on 11 February, 2026 | 22:13
The PB ratio of AstraZeneca Pharma India is 28.4 As on 11 February, 2026 | 22:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.